-- Salesforce (CRM) said Tuesday that Moderna (MRNA) has selected its Agentforce Life Sciences platform to consolidate commercial operations worldwide.
The platform will combine data, artificial intelligence, and customer interactions across multiple regions into a single system, Salesforce said.
The agreement allows the drugmaker to integrate information from different networks to generate real-time insights for cross-channel promotional campaigns, Salesforce said.
The software's open architecture will connect various operations to support Moderna in scaling without vendor restrictions, the company added.
Price: $182.49, Change: $+2.31, Percent Change: +1.28%